French company Wandercraft is taking a groundbreaking step forward to give individuals with disabilities a chance to walk again. The company is using cutting-edge technology to develop the world's ...
The Food and Drug Administration (FDA) has approved Wandercraft's Atalante exoskeleton for stroke rehabilitation, as reported by Engadget. David Zabala, an 8-year-old boy with cerebral palsy, is ...
This marks Wandercraft’s second FDA clearance for Atalante X, the world’s first self-balancing exoskeleton, following clearance for stroke rehabilitation in December 2022 FDA clearance paves the way ...
Stroke patients in the US could soon take advantage of cutting-edge robotics during the recovery process. The Food and Drug Administration has cleared Wandercraft's Atalante exoskeleton for use in ...
Exclusive in-person and virtual event today (link below) will reveal a groundbreaking innovation in robotics engineering from Wandercraft ahead of product finalization and market launch Once cleared, ...
, a Paris-based exoskeleton startup, allows the wearer to freely move their upper body and torso with the company's hands-free feature. Also, it is used to help physical therapy patients walk faster ...
NEW YORK, US and PARIS, France, 13 July 2023-- Wandercraft, the developer of the world's first self-stabilized walking exoskeleton, designed to enable people with walking impairments to stand up and ...
Wandercraft, a maker of self-balancing robotic mobility systems, has secured $75 million in funding to accelerate AI-powered robotics. This influx of capital arrives during a time of rapid growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results